Surrozen, Inc./DE — Director's Dealing 2021

Aug 21, 2021

SEC Form 3/A — Form 3/A

Issuer: Surrozen, Inc./DE (SRZN)
CIK: 0001824893
Period of Report: 2021-08-11

Reporting Person: Yeh Wen-Chen (Chief Scientific Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.25	2028-12-31	Common Stock (8782)		Direct
Employee Stock Option (right to buy)	$2.96	2030-02-12	Common Stock (35129)		Direct
Employee Stock Option (right to buy)	$10.76	2031-02-22	Common Stock (35129)		Direct

Footnotes

F1: 1/48th of the shares subject to the Stock Option shall vest on each monthly anniversary of the vesting commencement date over a four-year period.

F2: Received pursuant to the Business Combination Agreement (the "BCA"), dated April 15, 2021, by and among the Issuer (fka "Consonance-HFW Acquisition Corp"), Perseverance Merger Sub Inc. ("Merger Sub"), and Surrozen, Inc. (the "Original Surrozen"). Under the terms of the BCA, among other things, Merger Sub merged with and into the Original Surrozen, with Original Surrozen surviving as a wholly-owned subsidiary of the Issuer (the "Business Combination"), the Original Surrozen changed its name to Surrozen Operating, Inc., and the Issuer changed its name to Surrozen, Inc. In addition, per the terms of the BCA, each share and equity award of the Original Surrozen outstanding as of effective time of the Business Combination was exchanged for shares of the Issuer's Common Stock or comparable equity awards that are settled or are exercisable for shares of the Issuer's Common Stock, as applicable, at the exchange ratio of 0.175648535.

F3: This amendment is being filed to correct a typographical error in the exercise prices of the Stock Options which were incorrectly reported on the original filed Form 3.